More emphasis should be given on investing healthcare resources towards prevention of diseases rather than only focusing on diagnostic and therapeutic options
The pooled prevalence of GERD in the Indian population is 15.6 %
Dyslipidemia is a critical risk factor for cardiovascular diseases
Launches collaborative centre for translational research in head and neck cancer
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
Subscribe To Our Newsletter & Stay Updated
